Role of herbal medicine in Gout disease

A comparative clinical study of the effect of Siravedh and Gudaharitaki in the management of Vatarakta w.s.r. to Gout

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071522

Enrollment

Registered

2024-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of classical sign and symptoms of Vatarakta (Gout)with serum uric acid level greater than 7mg/dl in males and 6mg/dl in females. 2. Age 16 to 70 years, of either sex. 3. Patients willing to undergo trial.

Exclusion criteria

Exclusion criteria: 1. Not willing to undergo trial. 2. Patients having other associated arthropathies. 3. Patients taking modern medicines like uricosuric or xanthine oxidase inhibitors. 4. Contraindication of Siravedh. 5. Patients suffering from any bleeding disorders, pregnancy, anemia, uncontrolled diabetes mellitus will be excluded from the study. 6. Existing or less than 2 weeks ago oral treatment with corticosteroids or colchicine

Design outcomes

Primary

Measure	Time frame
relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in BloodTimepoint: 2 months	—

Secondary

Measure	Time frame
relief in sign and symptoms of Vatarakta (Gout), decrease level of Uric acid in BloodTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Prem Kumar

Madan Mohan Malviya Government Ayurved College, Udaipur (Rajasthan)

prof.maheshdixit@gmail.com9714245459

Outcome results